Abstract
This chapter discusses the development of the bone-forming cells that are all descendants from the mesenchymal stem cells (MSCs). MSCs have the ability to self-renew and provide a pool for osteoprogenitors. However, MSCs can also differentiate into cells of the mesodermal cell line, which besides the bone-forming cells include chondroblasts, adipocytes, and muscle cells. Hormones, local factors, and the extracellular matrix program the MSCs into the distinct differentiation pathways. Especially, the inverse relationship between osteogenesis and adipogenesis plays a pivotal role for bone formation and maintenance of the bone. During differentiation of the osteoblastic lineage, cells pass distinct states with distinct roles in the bone-forming process, i.e., matrix synthesis and mineralization as well as regulation of bone remodeling which appears to be mainly directed by osteocytes. Moreover, osteocytes have important endocrine functions as they secrete factors into circulation that regulate other organs of the body.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bianco P. Bone and the hematopoietic niche: a tale of two stem cells. Blood. 2011;117(20):5281–8.
Scadden DT. Nice neighborhood: emerging concepts of the stem cell niche. Cell. 2014;157(1):41–50.
Bethel M, Chitteti BR, Srour EF, Kacena MA. The changing balance between osteoblastogenesis and adipogenesis in aging and its impact on hematopoiesis. Curr Osteoporos Rep. 2013;11(2):99–106.
Wu JY, Purton LE, Rodda SJ, et al. Osteoblastic regulation of B lymphopoiesis is mediated by Gs{alpha}-dependent signaling pathways. Proc Natl Acad Sci U S A. 2008;105(44):16976–81.
Kode A, Manavalan JS, Mosialou I, et al. Leukaemogenesis induced by an activating beta-catenin mutation in osteoblasts. Nature. 2014;506(7487):240–4.
Chen Q, Shou P, Zheng C, et al. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ. 2016;23(7):1128–39.
Karsenty G. Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet. 2008;9:183–96.
Akiyama H, Kim JE, Nakashima K, et al. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc Natl Acad Sci U S A. 2005;102(41):14665–70.
Zhou G, Zheng Q, Engin F, et al. Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci U S A. 2006;103(50):19004–9.
Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology. 2001;142(12):5050–5.
Sroga GE, Vashishth D. Effects of bone matrix proteins on fracture and fragility in osteoporosis. Curr Osteoporos Rep. 2012;10(2):141–50.
Thompson WR, Modla S, Grindel BJ, et al. Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone. J Bone Miner Res. 2011;26(3):618–29.
Staines KA, MacRae VE, Farquharson C. The importance of the SIBLING family of proteins on skeletal mineralisation and bone remodelling. J Endocrinol. 2012;214(3):241–55.
Fukumoto S, Martin TJ. Bone as an endocrine organ. Trends Endocrinol Metab. 2009;20(5):230–6.
Kim SW, Pajevic PD, Selig M, et al. Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts. J Bone Miner Res. 2012;27(10):2075–84.
Neve A, Corrado A, Cantatore FP. Osteoblast physiology in normal and pathological conditions. Cell Tissue Res. 2011;343(2):289–302.
Everts V, Delaisse JM, Korper W, et al. The bone lining cell: its role in cleaning Howship’s lacunae and initiating bone formation. J Bone Miner Res. 2002;17(1):77–90.
Varga F, Luegmayr E, Fratzl-Zelman N, et al. Tri-iodothyronine inhibits multilayer formation of the osteoblastic cell line, MC3T3-E1, by promoting apoptosis. J Endocrinol. 1999;160(1):57–65.
Bodine PV. Wnt signaling control of bone cell apoptosis. Cell Res. 2008;18(2):248–53.
Mikuni-Takagaki Y, Kakai Y, Satoyoshi M, et al. Matrix mineralization and the differentiation of osteocyte-like cells in culture. J Bone Miner Res. 1995;10(2):231–42.
van der Plas A, Nijweide PJ. Isolation and purification of osteocytes. J Bone Miner Res. 1992;7(4):389–96.
Dallas SL, Prideaux M, Bonewald LF. The osteocyte: an endocrine cell ... and more. Endocr Rev. 2013;34(5):658–90.
Buenzli PR, Sims NA. Quantifying the osteocyte network in the human skeleton. Bone. 2015;75:144–50.
Batra N, Kar R, Jiang JX. Gap junctions and hemichannels in signal transmission, function and development of bone. Biochim Biophys Acta. 2012;1818(8):1909–18.
Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013;19(2):179–92.
Kim SW, Lu Y, Williams EA, et al. Sclerostin antibody administration converts bone lining cells into active osteoblasts. J Bone Miner Res. 2016;32(5):892–901.
Xiong J, O’Brien CA. Osteocyte RANKL: new insights into the control of bone remodeling. J Bone Miner Res. 2012;27(3):499–505.
Jilka RL, Noble B, Weinstein RS. Osteocyte apoptosis. Bone. 2013;54(2):264–71.
Plotkin LI, Bellido T. Osteocytic signalling pathways as therapeutic targets for bone fragility. Nat Rev Endocrinol. 2016;12(10):593–605.
Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp. 1988;136:42–60.
Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008;2(4):313–9.
Aubin JE. Regulation of osteoblast formation and function. Rev Endocr Metab Disord. 2001;2(1):81–94.
Fedde KN. Human osteosarcoma cells spontaneously release matrix-vesicle-like structures with the capacity to mineralize. Bone Miner. 1992;17(2):145–51.
Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 1987;51(6):987–1000.
Ahrens M, Ankenbauer T, Schroder D, Hollnagel A, Mayer H, Gross G. Expression of human bone morphogenetic proteins-2 or −4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol. 1993;12(10):871–80.
Wang EA, Israel DI, Kelly S, Luxenberg DP. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors. 1993;9(1):57–71.
Udagawa N, Takahashi N, Akatsu T, et al. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology. 1989;125(4):1805–13.
Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol. 1983;96(1):191–8.
Varga F, Rumpler M, Luegmayr E, Fratzl-Zelman N, Glantschnig H, Klaushofer K. Triiodothyronine, a regulator of osteoblastic differentiation: depression of histone H4, attenuation of c-fos/c-jun, and induction of osteocalcin expression. Calcif Tissue Int. 1997;61(5):404–11.
Luegmayr E, Varga F, Frank T, Roschger P, Klaushofer K. Effects of triiodothyronine on morphology, growth behavior, and the actin cytoskeleton in mouse osteoblastic cells (MC3T3-E1). Bone. 1996;18(6):591–9.
Fratzl-Zelman N, Horandner H, Luegmayr E, et al. Effects of triiodothyronine on the morphology of cells and matrix, the localization of alkaline phosphatase, and the frequency of apoptosis in long-term cultures of MC3T3-E1 cells. Bone. 1997;20(3):225–36.
Fratzl-Zelman N, Fratzl P, Horandner H, et al. Matrix mineralization in MC3T3-E1 cell cultures initiated by beta-glycerophosphate pulse. Bone. 1998;23(6):511–20.
Zhou X, Cui Y, Han J. Phosphate/pyrophosphate and MV-related proteins in mineralisation: discoveries from mouse models. Int J Biol Sci. 2012;8(6):778–90.
Prideaux M, Schutz C, Wijenayaka AR, et al. Isolation of osteocytes from human trabecular bone. Bone. 2016;88:64–72.
Shah KM, Stern MM, Stern AR, Pathak JL, Bravenboer N, Bakker AD. Osteocyte isolation and culture methods. Bonekey Rep. 2016;5:838.
Kerschnitzki M, et al. The organization of the osteocyte network mirrors the extracellular matrix orientation in bone. J Struct Biol. 2011;173:303–11.
Acknowledgments
The authors are very grateful to Univ. Prof. Dr. Klaus Klaushofer, Director of the Ludwig Boltzmann Institute of Osteology, for the continuous support and many discussions about bone biology and its relevance for the clinic.
The work was supported by the AUVA (Research funds of the Austrian workers compensation board) and by the WGKK (Viennese sickness insurance funds).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Fratzl-Zelman, N., Varga, F. (2017). Osteoblasts and Osteocytes: Essentials and Methods. In: Pietschmann, P. (eds) Principles of Bone and Joint Research. Learning Materials in Biosciences. Springer, Cham. https://doi.org/10.1007/978-3-319-58955-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-58955-8_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-58954-1
Online ISBN: 978-3-319-58955-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)